XORTX Therapeutics Inc. submitted a Form 6-K filing to the SEC on March 13, 2026, indicating they have filed their annual reports under Form 20-F. This filing is considered a neutral event for investors.
AI Assistant
XORTX THERAPEUTICS INC
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.